They stimulate insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is released only when blood glucose levels are elevated
For more details, check the USPTOs patent database or follow updates on X for real-time industry sentiment.
Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector
"You are getting hate for existing in a bigger body, which is messed up," says fashion journalist Evelyn Ebrey, who has just produced the documentary series Cutting the Curve, on plus-sized models
Jumping to a higher dose too quickly is the most common reason for severe side effects like vomiting or intense abdominal pain